Paul Mcbarron serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Paul Mcbarron has executed 11 insider transactions totaling $55.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 21, 2023 involved purchasing 1,886 shares valued at $6.3K.
Paul Mcbarron currently holds 33,378 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Mcbarron has been a net buyer of CYCC stock. They have purchased $55.9K and sold $0 worth of shares.
Paul Mcbarron's most recent insider trade was on Dec 21, 2023, when they purchased 1,886 shares at $3.32 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 21, 2013 | CYCC | $14.2K | Purchase | 4,615 | $3.08 | Discretionary |
| May 21, 2013 | CYCC | $25.0K | Purchase | 8,333 | $3.00 | Discretionary |
| Jan 25, 2013 | CYCC | $0 | Award | 6,712 | $N/A | Discretionary |
| Jan 25, 2013 | CYCC | $0 | Award | 20,000 | $N/A | Discretionary |
| Dec 6, 2011 | CYCC | $0 | Award | 75,000 | $N/A | Discretionary |
| Sep 23, 2011 | CYCC | $6.0K | Purchase | 12,000 | $0.50 | Discretionary |
| Nov 18, 2008 | CYCC | $0 | Award | 50,000 | $N/A | Discretionary |
| May 22, 2008 | CYCC | $4.4K | Purchase | 1,950 | $2.25 | Discretionary |
| Mar 27, 2006 | CYCC | $0 | Other | 74,104 | $N/A | Discretionary |